title: Multifocal polyclonal Epstein-Barr virus-associated B-cell lymphoproliferative disorder secondary to azathioprine therapy successfully treated with rituximab.
authors.forename: Stéphane
authors.initials: S
authors.lastname: Courby
authors.forename: Blandine
authors.initials: B
authors.lastname: Fabre
authors.forename: Dimitri
authors.initials: D
authors.lastname: Salameire
authors.forename: Philippe
authors.initials: P
authors.lastname: Gaulard
authors.forename: Virginie
authors.initials: V
authors.lastname: Hincky-Vitrat
authors.forename: Rémy
authors.initials: R
authors.lastname: Gressin
authors.forename: Bruno
authors.initials: B
authors.lastname: Bonaz
authors.forename: Olivier
authors.initials: O
authors.lastname: Epaulard
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use*; D001402:B-Lymphocytes / Q000276:immunology*; D003424:Crohn Disease / Q000150:complications; D005260:Female; D004854:Herpesvirus 4, Human / Q000378:metabolism*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008171:Lung Diseases / Q000150:complications / Q000175:diagnosis / Q000821:virology; D008232:Lymphoproliferative Disorders / Q000188:drug therapy* / Q000821:virology; D000069283:Rituximab; D014057:Tomography, X-Ray Computed / Q000379:methods; D016896:Treatment Outcome
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D007166:Immunosuppressive Agents; D000069283:Rituximab; D001379:Azathioprine